Yes, carbapenems can interact with certain cancer therapies. For instance, they may alter the metabolism of some chemotherapeutic agents, affecting their efficacy or increasing toxicity. It is crucial to have a multidisciplinary team, including oncologists and infectious disease specialists, to manage these patients effectively.
